Literature DB >> 28479364

Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide.

Takeshi Miyake1, Tadahaya Mizuno1, Tatsuki Mochizuki1, Miyuki Kimura2, Shunji Matsuki2, Shin Irie2, Ichiro Ieiri3, Kazuya Maeda1, Hiroyuki Kusuhara4.   

Abstract

Recent studies suggest that trimethylamine N-oxide (TMAO) is associated with the development of chronic kidney disease and heart failure. In this study, we investigated the importance of organic cation transporters (OCTs) in the clearance and tissue distribution of TMAO. The low-affinity and high-capacity transport of TMAO by mouse and human OCT1 and OCT2 was observed. Uptake and efflux of TMAO by the mouse hepatocytes as well as TMAO uptake into mouse kidney slices were significantly decreased by the addition of tetraethylammonium or Oct1/2 double knockout (dKO). Plasma concentrations of endogenous TMAO and TMAO-d9 given by intravenous infusion was 2-fold higher in Oct1/2 dKO than in wild-type mice due to significant decrease in its renal clearance. These results indicate that OCTs have a crucial role in the kinetics of TMAO in mice. In human, however, the OCT2-mediated tubular secretion in the urinary excretion of TMAO was insignificant because the renal clearance of TMAO was similar to that of creatinine in both young and elderly subjects, suggesting the species difference in the urinary excretion mechanisms of TMAO between mouse and human.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  elderly; hepatic transport; hepatocytes; organic cation transporters (OCTs); renal clearance

Mesh:

Substances:

Year:  2017        PMID: 28479364     DOI: 10.1016/j.xphs.2017.04.067

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  16 in total

1.  Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.

Authors:  G Latkovskis; E Makarova; M Mazule; L Bondare; D Hartmane; H Cirule; S Grinberga; A Erglis; E Liepinsh; M Dambrova
Journal:  Br J Clin Pharmacol       Date:  2018-09-06       Impact factor: 4.335

2.  Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.

Authors:  Hima Sapa; Orlando M Gutiérrez; Michael G Shlipak; Ronit Katz; Joachim H Ix; Mark J Sarnak; Mary Cushman; Eugene P Rhee; Paul L Kimmel; Ramachandran S Vasan; Sarah J Schrauben; Harold I Feldman; Jesse C Seegmiller; Henri Brunengraber; Thomas H Hostetter; Jeffrey R Schelling
Journal:  Am J Kidney Dis       Date:  2022-03-26       Impact factor: 11.072

3.  Trimethylamine-N-oxide acutely increases cardiac muscle contractility.

Authors:  Carlee I Oakley; Julian A Vallejo; Derek Wang; Mark A Gray; LeAnn M Tiede-Lewis; Tilitha Shawgo; Emmanuel Daon; George Zorn; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-03       Impact factor: 4.733

Review 4.  Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.

Authors:  Daniel Y Li; W H Wilson Tang
Journal:  Semin Nephrol       Date:  2018-03       Impact factor: 5.299

5.  Targeting OCT3 attenuates doxorubicin-induced cardiac injury.

Authors:  Kevin M Huang; Megan Zavorka Thomas; Tarek Magdy; Eric D Eisenmann; Muhammad Erfan Uddin; Duncan F DiGiacomo; Alexander Pan; Markus Keiser; Marcus Otter; Sherry H Xia; Yang Li; Yan Jin; Qiang Fu; Alice A Gibson; Ingrid M Bonilla; Cynthia A Carnes; Kara N Corps; Vincenzo Coppola; Sakima A Smith; Daniel Addison; Anne T Nies; Ralf Bundschuh; Taosheng Chen; Maryam B Lustberg; Joanne Wang; Stefan Oswald; Moray J Campbell; Pearlly S Yan; Sharyn D Baker; Shuiying Hu; Paul W Burridge; Alex Sparreboom
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

Review 6.  Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models.

Authors:  Bastian Haberkorn; Martin F Fromm; Jörg König
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

7.  Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO).

Authors:  A Gessner; J König; M F Fromm
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

Review 8.  Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Authors:  Esmeralda Castillo-Rodriguez; Raul Fernandez-Prado; Raquel Esteras; Maria Vanessa Perez-Gomez; Carolina Gracia-Iguacel; Beatriz Fernandez-Fernandez; Mehmet Kanbay; Alberto Tejedor; Alberto Lazaro; Marta Ruiz-Ortega; Emilio Gonzalez-Parra; Ana B Sanz; Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Toxins (Basel)       Date:  2018-07-19       Impact factor: 4.546

9.  Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.

Authors:  Caroline C Pelletier; Mikael Croyal; Lavinia Ene; Audrey Aguesse; Stephanie Billon-Crossouard; Michel Krempf; Sandrine Lemoine; Fitsum Guebre-Egziabher; Laurent Juillard; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2019-11-01       Impact factor: 4.546

Review 10.  Uremic Toxin Clearance and Cardiovascular Toxicities.

Authors:  Robert D Mair; Tammy L Sirich; Timothy W Meyer
Journal:  Toxins (Basel)       Date:  2018-06-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.